Preplaced cell division: A critical mechanism of autoprotection against S-1,2-dichlorovinyl-L-cysteine-induced acute renal failure and death in mice

American Journal of Physiology - Renal Physiology

Volumn 291, Issue 2, 2006, Pages

  Korrapati, Midhun C ^a   Chilakapati, Jaya ^a   Lock, Edward A ^b   Latendresse, John R ^c   Warbritton, Alan ^c   Mehendale, Harihara M ^a  

^a UNIVERSITY OF LOUISIANA AT MONROE   (United States)

^b LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

^c NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

Colchicine; Phospho retinoblastoma; Tissue repair

Indexed keywords

BROXURIDINE; COLCHICINE; CREATININE; CYCLIN DEPENDENT KINASE; EOSIN; HEMATOXYLIN; NITROGEN; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE 1; RETINOBLASTOMA PROTEIN; S (1,2 DICHLOROVINYL)CYSTEINE; UREA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL DIVISION; CELL PROTECTION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; HISTOPATHOLOGY; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY NECROSIS; LETHAL DOSE; MALE; MICROSCOPY; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; STAINING; TISSUE REPAIR; UREA NITROGEN BLOOD LEVEL;

EID: 33746639614     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00384.2005     Document Type: Article

References (68)

1. Andreucci M, Michael A, Kramers C, Park KM, Pioquinto R, Chen A, Macheaux T, Haq S, Force T, Alessandrini A, and Bonventre JV. Differential activation in ERK 1/2 phosphatidylionositol-3 kinase Akt/PKB pathways in renal ischemia. Nephrol Dial Transplant 17: 37, 2002.
2. 53 activation in response to microtubule disruption is mediated by integrin-Erk signaling. Oncogene 20: 899-909, 2001.
3. Behrend T and Miller SB. Acute renal failure in the cardiac care unit: etiologies, outcomes, and prognostic factors. Kidney Int 56: 238-243, 1999.
4. Bennett WM. Posttransplant acute renal failure. Ren Fail 19: 225-226, 1997.
5. Bonventre JV. Kidney ischemic preconditioning. Curr Opin Nephrol Hypertens 11: 43-48, 2002.
6. Borkan SC and Gullans SR. Molecular chaperones in the kidney. Annu Rev Physiol 64: 503-527, 2002.
7. Brivet FG, Kleinknecht DJ, Loirat P, and Landais PJ. Acute renal failure in intensive care units: causes, outcome, and prognostic factors of hospital mortality: a prospective, multicenter study. Crit Care Med 24: 192-198, 1996.
8. Chanda S, Mangipudy RS, Warbritton A, Bucci T, and Mehendale HM. Stimulated hepatic tissue repair underlies heteroprotection by thioacetamide against acetaminophen-induced lethality. Hepatology 21: 477-486, 1995.
9. Clermont G, Acker CG, Angus DC, Sirio CA, Pinsky MR, and Johnson JP. Renal failure in the ICU: comparison of the impact of acute renal failure and end-stage renal disease on ICU outcomes. Kidney Int 62: 986-996, 2002.
10. De Mendonca A, Vincent JL, and Suter PM. Acute renal failure in the ICU: risk factors and outcome evaluated by the SOFA score. Intensive Care Med 26: 915-921, 2000.
11. Dnyanmote AV, Sawant SP, Lock EA, Latendresse JR, and Mehendale HM. Calpastatin overexpression prevents progression of S-1,2-dichlorovinyl-L- cysteine (DCVC)-initiated acute renal injury and renal failure (ARF) in diabetes. Toxicol Appl Pharmacol In press.
12. Dnyanmote AV, Sawant SP, Lock EA, Latendresse JR, Warbritton AA, and Mehendale HM. Diabetic mice are protected from normally lethal nephrotoxicity of S-1,2-dichlorovinyl-L-cysteine (DCVC): role of nephrogenic tissue repair. Toxicol Appl Pharmacol 211: 133-147, 2005.
13. DuBose TD Jr, Warnock DG, Mehta RL, Bonventre JV, Hammerman MR, Molitoris BA, Paller MS, Siegel NJ, Scherbenske J, and Striker GE. Acute renal failure in the 21st century: recommendations for management and outcomes assessment. Am J Kidney Dis 29: 793-799, 1997.
14. Feliers D, Frank MA, and Riley DJ. Activation of cyclin D1/Cdk4 and Cdk4-directed phosphorylation of RB protein in diabetic mesangial hypertrophy. Diabetes 51: 3290-3299, 2002.
15. 35S]S-1,2-dichlorovinyl)-L-cysteine in the male Fischer 344 rat. Drug Metab Dispos 23: 124-128, 1995.
16. Franca P and Emma VM. Association of protein phosphatase-1 delta with the retinoblastoma protein and reversible phosphatase activation in mitotic HeLa cells and in cells released from mitosis. Biochem Biophys Res Commun 235: 704-708, 1997.
17. Heyman SN, Lieberthal W, Rogiers P, and Bonventre JV. Animal models of acute tubular necrosis. Curr Opin Crit Care 8: 526-534, 2002.
18. Huang CC, Takaharu I, Stevens JL, and Bonventre JV. Protection of renal epithelilal cells against oxidative injury by endoplasmic reticulum stress preconditioning is mediated by ERK 1/2 activation. J Biol Chem 278: 29317-29326, 2003.
19. Hunter T and Pines J. Cyclins and cancer. II. Cyclin D and CDK inhibitors come of age. Cell 79: 573-582, 1994.
20. Isotani S, Fujisawa M, Ishimura T, Arakawa S, and Kamidono S. Okadaic acid, an inhibitor of protein phosphatase, exerts a protective effect on ischemia-reperfusion injury in rat kidneys. Transplant Proc 34: 1345-1348, 2002.
21. Kathleen DL. Molecular mechanisms of recovery from acute renal failure. Crit Care Med 31: S572-S581, 2003.
22. Katrien V, Dirk RV, and Zwi NB. The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif 36: 131-149, 2003.
23. Korrapati MC, Lock EA, and Mehendale HM. Molecular mechanisms of enhanced renal cell division in protection against S-1,2-dichlorovinyl-L-cysteine- induced acute renal failure and death. Am J Physiol Renal Physiol 289: F175-F185, 2005.
24. Kulkarni SG, Warbritton A, Bucci TJ, and Mehendale HM. Antimitotic intervention with colchicine alters the outcome of O-DCB-induced hepatotoxicity in F344 rats. Toxicology 120: 79-88, 1997.
25. Kwon YG, Lee SY, Choi Y, Greengard P, and Nairn AC. Cell cycle-dependent phosphorylation of mammalian protein phosphatase-1 by cdc2 kinase. Proc Natl Acad Sci USA 94: 2168-2173, 1997.
26. Liano F, Junco E, Pascual J, Madero R, and Verde E. The spectrum of acute renal failure in the intensive care unit compared with that seen in other settings. The Madrid Acute Renal Failure Study Group. Kidney Int 66: S16-S24, 1998.
27. Lieberthal W and Nigam SK. Acute renal failure. II. Experimental models of acute renal failure: imperfect but indispensable. Am J Physiol Renal Physiol 278: F1-F12, 2000.
28. 27a. Limaye PB, Bhave VS, Palkar PS, Apte UM, Sawant SP, Yu S, Latendresse JR, Reddy JK, and Mehendale HM. Upregulation of calpastatin in regenerating and developing liver: Role in resistance against hepatotoxicity. Hepatology. In press.
29. Lundberg AS and Weinberg RA. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol Cell Biol 18: 753-761, 1998.
30. Manfredi JJ and Horwitz SB. Taxol: an antimitotic agent with a new mechanism of action. Pharmacol Ther 25: 83-125, 1984.
31. Mangipudy RS, Chanda S, and Mehendale HM. Hepatocellular regeneration: key to thioacetamide autoprotection. Pharmacol Toxicol 77: 182-188, 1995.
32. Mangipudy RS, Rao PS, and Mehendale HM. Effect of antimitotic agent colchicine on thioacetamide hapatotoxicity. Environ Health Perspect 104: 744-749, 1996.
33. Mehendale HM, Thakore KN, and Rao CV. Autoprotection: stimulated tissue repair permits recovery from injury. J Biochem Toxicol 9: 131-139, 1994.
34. Mene P, Polci R, and Festuccia F. Mechanisms of repair after kidney injury. J Nephrol 16: 186-195, 2003.
35. Metcalfe W, Simpson M, Khan IH, Prescott GJ, Simpson K, Smith WC, and MacLeod AM. Acute renal failure requiring renal replacement therapy: incidence and outcome. Q J Med 95: 579-583, 2002.
36. Morgan DO. Principles of CDK regulation. Nature 374: 131-134, 1995.
37. Nissenson A. Acute renal failure: definition and pathogenesis. Kidney Int 53: S7-S10, 1998.
38. Nolan C and Anderson R. Hospital-aquired acute renal failure. J Am Soc Nephrol 9: 710-718, 1998.
39. Park KM, Byun JY, Kramers C, Kim JI, Huang PL, and Bonventre JV. Inducible nitric oxide synthase is an important contributor to prolonged protective effects of ischemic preconditioning in the mouse kidney. J Biol Chem 278: 27256-27266, 2003.
40. Park KM, Kramers C, Vayssier-Taussat M, Chen A, and Bonventre JV. Prevention of kidney ischemia/reperfusion-induced functional injury, MAPK and MAPK kinase activation, and inflammation by remote transient ureteral obstruction. J Biol Chem 227: 2040-2049, 2002.
41. Park SK, Kang MJ, Kim W, and Koh GY. Renal tubule regeneration after ischemic injury is coupled to the upregulation and activation of cyclins and cyclin dependent kinases. Kidney Int 52: 706-714, 1997.
42. Park SK, Kang SK, Lee DY, Kang MJ, Kim SH, and Koh GY. Temporal expressions of cyclins and cyclin dependent kinases during renal development and compensatory growth. Kidney Int 51: 762-769, 1997.
43. Park SK, Kim W, Lee CH, and Koh GY. Differential changes of CDK activities in glomeruli and tubules during the active DNA synthetic period after ischemic injury. Nephron 86: 306-314, 2002.
44. Portilla D, Dai G, Peters JM, Gonzalez FJ, Crew MD, and Proia AD. Etomoxir-induced PPAR′22-modulated enzymes protect during acute renal failure. Am J Physiol Renal Physiol 278: F667-F675, 2000.
45. Pruchnicki MC and Dasta JF. Acute renal failure in hospitalized patients: part I. Ann Pharmacother 36: 1261-1267, 2002.
46. Puntoni F and Villa-Moruzzi E. Protein phosphatase-1 activation and association with the retinoblastoma protein in colcemid-induced apoptosis. Biochem Biophys Res Commun 266: 279-283, 1999.
47. 4 autoprotection. Toxicol Pathol 19: 597-606, 1991.
48. 4 treated rats. Biochem Pharmacol 42: 2323-2332, 1991.
49. Rosen S and Heyman SN. Difficulties in understanding human "acute tubular necrosis": limited data and flawed animal models. Kidney Int 60: 1220-1224, 2001.
50. Ruffner H and Verma IM. BRCA1 is a cell-regulated nuclear phosphoprotein. Proc Natl Acad Sci USA 94: 7138-7143, 1997.
51. 3H]thymidine administered by injection or osmotic pump. Carcinogenesis 11: 2245-2251, 1990.
52. Savatier P, Huang S, Szekely L, Wiman KG, and Samarut J. Contrasting patterns of retinoblastoma protein expression in mouse embryonic stem cells and embryonic fibroblasts. Oncogene 9: 809-818, 1994.
53. 1/S transition phase in mesangial cells by E2F1. Kidney Int 56: 1238-1241, 1999.
54. Sherr CJ. Mammalian G1 cyclins. Cell 73: 1059-1065, 1993.
55. 1 cyclin dependent kinases. Genes Dev 9: 1149-1163, 1995.
56. Siwanon J, Aileen A, Evan CO, David SM, Rhonda DK, and Hiroaki K. Cdk4 is indispensable for postnatal proliferation of the anterior pituitary. J Biol Chem 279: 51100-51106, 2004.
57. Star R. Treatment of acute renal failure. Kidney Int 54: 1817-1831, 1998.
58. Sutton TA, Fisher CJ, and Molitoris BA. Microvascular endothelial injury and dysfunction during ischemic acute renal failure. Kidney Int 62: 1539-1549, 2002.
59. Takemura T, Hino S, Okada M, Murata Y, Yanagida H, Ikeda M, Yoshioka K, and Harris RC. Role of membrane-bound heparin-binding epidermal growth factor-like growth factor (HB-EGF) in renal epithelial cell branching. Kidney Int 61: 1968-1979, 2002.
60. Thadhani R, Pascual A, and Bonventre JV. Acute renal failure. N Engl J Med 334: 1448-1460, 1996.
61. Thomas JE, Smith M, Tonkinson JL, Rubinfeld B, and Polakis P. Induction of phosphorylation on BRCA1 during the cell cycle and after DNA damage. Cell Growth Differ 8: 801-809, 1997.
62. Tsukamoto I and Kojo S. Effect of colchicine and vincristine on DNA synthesis in regenerating rat liver. Biochem Biophys Acta 1009: 191-193, 1989.
63. Ueda N, Kaushal GP, and Shah SV. Apoptotic mechanisms in acute renal failure. Am J Med 108: 403-415, 2000.
64. Vaidya VS, Shankar K, Lock EA, Bucci TJ, and Mehendale HM. Renal injury and repair following S-(1,2-dichlorovinyl)-L-cysteine (DCVC) administration to mice. Toxicol Appl Pharmacol 188: 110-121, 2003.
65. Vaidya VS, Shankar K, Lock EA, Bucci TJ, and Mehendale HM. Role of tissue repair in survival from S-(1,2-dichlorovinyl)-L-cysteine (DCVC)-induced acute renal tubular necrosis in the mouse. Toxicol Sci 74: 215-227, 2003.
66. Vaidya VS, Shankar K, Lock EA, Dixon D, and Mehendale HM. Molecular mechanisms of renal tissue repair in survival from acute renal tubule necrosis: role of ERK1/2 pathway. Toxicol Pathol 31: 604-618, 2003.
67. Ying L, David MV, Raymond LW, and Lih CH. Regulation of BRCA1 phosphorylation by interaction with protein phosphatase 1α. Cancer Res 62: 6357-6361, 2002.
68. Ying Y and Marc CM. Distinct roles for PP-1 and PP-2A in phosphorylation of the retinoblastoma protein. J Biol Chem 274: 31917-31924, 1999.